lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)

Product Name
lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)
CAS No.
68039-65-6
Chemical Name
lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)
Synonyms
Einecs 268-272-5;Chromate(1-), bis{4-hydroxy-3-((3-methyl-5-oxo-1-phenyl-2-pyrazolin-4-yl)azo))benzenesulfonamidato(2-)}-, lithium;Lithium bis(3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxybenzenesulphonamidato(2-))chromate(1-);lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-);Chromate(1-), bis(3-((4,5-dihydro-3-methyl-5-(oxo-kappao)-1-phenyl-1H-pyrazol-4-yl)azo-kappan1)-4-(hydroxy-kappao)benzenesulfonamidato(2-))-, lithium;Chromate(1-), bis(3-(2-(4,5-dihydro-3-methyl-5-(oxo-kappao)-1-phenyl-1H-pyrazol-4-yl)diazenyl-kappan1)-4-(hydroxy-kappao)benzenesulfonamidato(2-))-, lithium (1:1)
CBNumber
CB8942568
Molecular Formula
C32H26CrLiN10O8S2
Formula Weight
801.67814
MOL File
68039-65-6.mol
More
Less

lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-) Property

EPA Substance Registry System
Chromate(1-), bis[3-[[4,5-dihydro-3-methyl-5-(oxo-.kappa.O)-1-phenyl-1H-pyrazol-4-yl]azo-.kappa.N1]-4-(hydroxy-.kappa.O)benzenesulfonamidato(2-)]-, lithium (68039-65-6)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H317May cause an allergic skin reaction

H411Toxic to aquatic life with long lasting effects

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P272Contaminated work clothing should not be allowed out of the workplace.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P321Specific treatment (see … on this label).

P333+P313IF SKIN irritation or rash occurs: Get medical advice/attention.

P363Wash contaminated clothing before reuse.

P501Dispose of contents/container to..…

lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-) Suppliers

Global 0

68039-65-6, lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)Related Search:


  • lithium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxybenzenesulphonamidato(2-)]chromate(1-)
  • Chromate(1-), bis(3-((4,5-dihydro-3-methyl-5-(oxo-kappao)-1-phenyl-1H-pyrazol-4-yl)azo-kappan1)-4-(hydroxy-kappao)benzenesulfonamidato(2-))-, lithium
  • Chromate(1-), bis(3-(2-(4,5-dihydro-3-methyl-5-(oxo-kappao)-1-phenyl-1H-pyrazol-4-yl)diazenyl-kappan1)-4-(hydroxy-kappao)benzenesulfonamidato(2-))-, lithium (1:1)
  • Chromate(1-), bis{4-hydroxy-3-((3-methyl-5-oxo-1-phenyl-2-pyrazolin-4-yl)azo))benzenesulfonamidato(2-)}-, lithium
  • Einecs 268-272-5
  • Lithium bis(3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxybenzenesulphonamidato(2-))chromate(1-)
  • 68039-65-6